DVAX - DYNAVAX TECHNOLOGIES CORP

QQQ $ 479.12 $ -2.18 (-0.45 %)

DIA $ 408.82 $ -0.07 (-0.02 %)

SPY $ 558.30 $ -0.86 (-0.15 %)

TLT $ 98.32 $ 0.01 (0.02 %)

GLD $ 233.38 $ -0.35 (-0.15 %)

Previous Close

$ 11.45

Open

$ 11.40

Bid

$ 11.32 x 100

Ask

$ 11.34 x 100

Day's Range

$ 11.32 - $ 11.40

52 Week Range

$ 9.74 - $ 15.15

Volume

1,705,133

Average Volume

Market Cap

1.77B

Beta (5Y Monthly)

$ 1.09

PE Ratio (TTM)

$ 102.97

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-06-2024	06-30-2024	10-Q
2	05-08-2024	03-31-2024	10-Q
3	02-22-2024	12-31-2023	10-K
4	11-02-2023	09-30-2023	10-Q
5	08-03-2023	06-30-2023	10-Q
6	05-02-2023	03-31-2023	10-Q
7	02-23-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-04-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	02-25-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	03-11-2020	12-31-2019	10-K
20	11-07-2019	09-30-2019	10-Q
21	08-07-2019	06-30-2019	10-Q
22	05-09-2019	03-31-2019	10-Q
23	02-27-2019	12-31-2018	10-K
24	11-06-2018	09-30-2018	10-Q
25	08-07-2018	06-30-2018	10-Q
26	05-09-2018	03-31-2018	10-Q
27	03-08-2018	12-31-2017	10-K
28	11-03-2017	09-30-2017	10-Q
29	08-07-2017	06-30-2017	10-Q
30	05-08-2017	03-31-2017	10-Q
31	03-13-2017	12-31-2016	10-K
32	11-07-2016	09-30-2016	10-Q
33	08-08-2016	06-30-2016	10-Q
34	05-09-2016	03-31-2016	10-Q
35	03-08-2016	12-31-2015	10-K
36	11-05-2015	09-30-2015	10-Q
37	08-07-2015	06-30-2015	10-Q
38	05-07-2015	03-31-2015	10-Q
39	03-05-2015	12-31-2014	10-K
40	11-05-2014	09-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Assessing Dynavax Technologies: Insights F...
08/08/2024 16:00:14

Goldman Sachs Maintains Neutral on Dynavax...
08/08/2024 15:21:07

Goldman Sachs analyst Paul Choi maintains Dynavax Technologies (NASDAQ:DVAX) with a Neutral and lowers the price target from...

HC Wainwright & Co. Reiterates Buy on Dyna...
08/07/2024 12:29:43

HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 pric...

Dynavax Reaffirms 2024 HEPLISAV-B Net Prod...
08/06/2024 21:00:11

Dynavax Technologies Q2 2024 GAAP EPS $0.0...
08/06/2024 20:19:18

Dynavax Technologies (NASDAQ:DVAX) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of ...

Dynavax Reappoints Kelly MacDonald As CFO ...
08/02/2024 20:09:36

HC Wainwright & Co. Reiterates Buy on Dyna...
06/28/2024 10:28:25

HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 pric...

Dynavax Initiates Phase 1/2 Study Of Novel...
06/27/2024 20:10:52

HC Wainwright & Co. Reiterates Buy on Dyna...
05/14/2024 15:19:48

HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 pric...

fda-declines-to-approve-expanded-use-of-dynavaxs-hepatitis-b-vaccine-in-hemodialysis-patients

FDA Declines To Approve Expanded Use of Dy...
05/14/2024 14:10:02

Latest regulatory update from Dynavax on HEPLISAV-B vaccine regimen for adults on hemodialysis, with FDA's Complete Respons...

FDA Issued Complete Response Letter To Dyn...
05/14/2024 12:35:48

HC Wainwright & Co. Reiterates Buy on Dyna...
05/09/2024 10:50:33

HC Wainwright & Co. analyst Edward White reiterates Dynavax Technologies (NASDAQ:DVAX) with a Buy and maintains $29 pric...

Dynavax Reaffirms Full Year 2024 Financial...
05/08/2024 20:56:05

HEPLISAV-B net product revenue between approximately $265 - $280 million, including approximately $3 million in ex-U.S. sales...

Dynavax Technologies Q1 2024 GAAP EPS $(0....
05/08/2024 20:02:29

Dynavax Technologies (NASDAQ:DVAX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate o...

Dynavax Technologies Sees FY24 Net Product...
02/22/2024 21:37:55

Dynavax Technologies: Q4 Earnings Insights
02/22/2024 21:05:13

Dynavax Technologies Q4 Sales $55.60M Beat...
02/22/2024 21:02:35

Dynavax Technologies (NASDAQ:DVAX) reported quarterly sales of $55.60 million which beat the analyst consensus estimate of $52....

Earnings Scheduled For February 22, 2024
02/22/2024 10:27:06

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

Goldman Sachs Initiates Coverage On Dynava...
02/01/2024 12:00:51

Goldman Sachs analyst Paul Choi initiates coverage on Dynavax Technologies (NASDAQ:DVAX) with a Neutral rating and announces...

why-rxsight-shares-are-trading-higher-by-20-here-are-other-stocks-moving-in-mondays-mid-day-session

Why RxSight Shares Are Trading Higher By 2...
01/08/2024 18:36:30

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24...